OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Navigating Alzheimer’s Disease via Chronic Stress: The Role of Glucocorticoids
Vivek Sharma, Thakur Gurjeet Singh
Current Drug Targets (2019) Vol. 21, Iss. 5, pp. 433-444
Closed Access | Times Cited: 24
Vivek Sharma, Thakur Gurjeet Singh
Current Drug Targets (2019) Vol. 21, Iss. 5, pp. 433-444
Closed Access | Times Cited: 24
Showing 24 citing articles:
Mechanistic insights and perspectives involved in neuroprotective action of quercetin
Amarjot Kaur Grewal, Thakur Gurjeet Singh, Deepak Sharma, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111729-111729
Open Access | Times Cited: 202
Amarjot Kaur Grewal, Thakur Gurjeet Singh, Deepak Sharma, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111729-111729
Open Access | Times Cited: 202
Apoptotic Pathways and Alzheimer’s Disease: Probing Therapeutic Potential
Vivek Sharma, Thakur Gurjeet Singh, Shareen Singh, et al.
Neurochemical Research (2021) Vol. 46, Iss. 12, pp. 3103-3122
Closed Access | Times Cited: 138
Vivek Sharma, Thakur Gurjeet Singh, Shareen Singh, et al.
Neurochemical Research (2021) Vol. 46, Iss. 12, pp. 3103-3122
Closed Access | Times Cited: 138
Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview
Eman E. Alshial, Muhammad Idris Abdulghaney, Al-Hassan Soliman Wadan, et al.
Life Sciences (2023) Vol. 334, pp. 122257-122257
Closed Access | Times Cited: 50
Eman E. Alshial, Muhammad Idris Abdulghaney, Al-Hassan Soliman Wadan, et al.
Life Sciences (2023) Vol. 334, pp. 122257-122257
Closed Access | Times Cited: 50
Dysbiosis and Alzheimer’s Disease: A Role for Chronic Stress?
Vivek Sharma, Thakur Gurjeet Singh, Nikhil Garg, et al.
Biomolecules (2021) Vol. 11, Iss. 5, pp. 678-678
Open Access | Times Cited: 87
Vivek Sharma, Thakur Gurjeet Singh, Nikhil Garg, et al.
Biomolecules (2021) Vol. 11, Iss. 5, pp. 678-678
Open Access | Times Cited: 87
Therapeutic implications of cyclooxygenase (COX) inhibitors in ischemic injury
Heena Khan, Kunal Sharma, Amit Kumar, et al.
Inflammation Research (2022) Vol. 71, Iss. 3, pp. 277-292
Closed Access | Times Cited: 43
Heena Khan, Kunal Sharma, Amit Kumar, et al.
Inflammation Research (2022) Vol. 71, Iss. 3, pp. 277-292
Closed Access | Times Cited: 43
Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?
Daniela Melchiorri, Sara Merlo, Benjamin Micallef, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 26
Daniela Melchiorri, Sara Merlo, Benjamin Micallef, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 26
An Interaction between Brain-Derived Neurotrophic Factor and Stress-Related Glucocorticoids in the Pathophysiology of Alzheimer’s Disease
Tadahiro Numakawa, Ryutaro Kajihara
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1596-1596
Open Access | Times Cited: 11
Tadahiro Numakawa, Ryutaro Kajihara
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1596-1596
Open Access | Times Cited: 11
Kynurenine Metabolism and Alzheimer’s Disease: The Potential Targets and Approaches
Vivek Sharma, Thakur Gurjeet Singh, Nirbhay Kumar Prabhakar, et al.
Neurochemical Research (2022) Vol. 47, Iss. 6, pp. 1459-1476
Closed Access | Times Cited: 29
Vivek Sharma, Thakur Gurjeet Singh, Nirbhay Kumar Prabhakar, et al.
Neurochemical Research (2022) Vol. 47, Iss. 6, pp. 1459-1476
Closed Access | Times Cited: 29
Stressed mitochondria: A target to intrude alzheimer’s disease
Vivek Sharma, Thakur Gurjeet Singh, Vineet Mehta
Mitochondrion (2021) Vol. 59, pp. 48-57
Closed Access | Times Cited: 37
Vivek Sharma, Thakur Gurjeet Singh, Vineet Mehta
Mitochondrion (2021) Vol. 59, pp. 48-57
Closed Access | Times Cited: 37
Regulation of mitochondrial dysfunction induced cell apoptosis is a potential therapeutic strategy for herbal medicine to treat neurodegenerative diseases
Ruolan Li, Ling‐Yu Wang, Huxinyue Duan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
Ruolan Li, Ling‐Yu Wang, Huxinyue Duan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
Glucocorticoid receptor antagonist CORT113176 attenuates motor and neuropathological symptoms of Huntington's disease in R6/2 mice
Max Gentenaar, Fleur L. Meulmeester, Ximaine van der Burg, et al.
Experimental Neurology (2024) Vol. 374, pp. 114675-114675
Open Access | Times Cited: 5
Max Gentenaar, Fleur L. Meulmeester, Ximaine van der Burg, et al.
Experimental Neurology (2024) Vol. 374, pp. 114675-114675
Open Access | Times Cited: 5
Interaction of aerobic exercise and crocin improves memory, learning and hypocampic tau and neurotrophins gene expression in rats treated with trimethytin as a model of Alzheimer’s disease
Mehrzad Moghadasi, Fatemeh Akbari, Parisa Najafi
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
Mehrzad Moghadasi, Fatemeh Akbari, Parisa Najafi
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
Alzheimer’s Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models)
A. Tolédano, Arantxa Rodrı́guez-Casado, María‐Isabel Álvarez, et al.
Brain Sciences (2024) Vol. 14, Iss. 11, pp. 1101-1101
Open Access | Times Cited: 3
A. Tolédano, Arantxa Rodrı́guez-Casado, María‐Isabel Álvarez, et al.
Brain Sciences (2024) Vol. 14, Iss. 11, pp. 1101-1101
Open Access | Times Cited: 3
Insights into the Mechanism of the Therapeutic Potential of Herbal Monoamine Oxidase Inhibitors in Neurological Diseases
Ashi Mannan, Thakur Gurjeet Singh, Varinder Singh, et al.
Current Drug Targets (2021) Vol. 23, Iss. 3, pp. 286-310
Closed Access | Times Cited: 20
Ashi Mannan, Thakur Gurjeet Singh, Varinder Singh, et al.
Current Drug Targets (2021) Vol. 23, Iss. 3, pp. 286-310
Closed Access | Times Cited: 20
Perceived Stress, Blood Biomarkers, and Cognitive Functioning in Older Adults
Pankaja Desai, Ted Kheng Siang Ng, Kristin R. Krueger, et al.
Psychosomatic Medicine (2024) Vol. 86, Iss. 6, pp. 507-511
Closed Access | Times Cited: 2
Pankaja Desai, Ted Kheng Siang Ng, Kristin R. Krueger, et al.
Psychosomatic Medicine (2024) Vol. 86, Iss. 6, pp. 507-511
Closed Access | Times Cited: 2
Sex Hormone Depletion Augments Glucocorticoid Induction of Tau Hyperphosphorylation in Male Rat Brain
Daniela Monteiro-Fernandes, Nuno Sousa, Osborne F. X. Almeida, et al.
Neuroscience (2020) Vol. 454, pp. 140-150
Closed Access | Times Cited: 18
Daniela Monteiro-Fernandes, Nuno Sousa, Osborne F. X. Almeida, et al.
Neuroscience (2020) Vol. 454, pp. 140-150
Closed Access | Times Cited: 18
The roles of natural triterpenoid saponins against Alzheimer's disease
Jie‐Chun Zhou, Huilin Li, Yu Zhou, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 5017-5040
Open Access | Times Cited: 6
Jie‐Chun Zhou, Huilin Li, Yu Zhou, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 5017-5040
Open Access | Times Cited: 6
Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study
Gemma García‐Lluch, Carmen Peña‐Bautista, Lucrecia Moreno, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 924-924
Open Access | Times Cited: 5
Gemma García‐Lluch, Carmen Peña‐Bautista, Lucrecia Moreno, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 924-924
Open Access | Times Cited: 5
A One-Stone-Two-Birds Strategy of Targeting Microbubbles with “Dual” Anti-Inflammatory and Blood–Brain Barrier “Switch” Function for Ischemic Stroke Treatment
Zhongbin An, Qiong He, Ling Jiang, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 3, pp. 1774-1787
Closed Access | Times Cited: 1
Zhongbin An, Qiong He, Ling Jiang, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 3, pp. 1774-1787
Closed Access | Times Cited: 1
Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination
Rupinder Kaur, Shareen Singh, Thakur Gurjeet Singh, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 1, pp. 1-21
Open Access | Times Cited: 4
Rupinder Kaur, Shareen Singh, Thakur Gurjeet Singh, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 1, pp. 1-21
Open Access | Times Cited: 4
Nuclear orphan receptors: A novel therapeutic agent in neuroinflammation
Kiran T. Thakur, Heena Khan, Amarjot Kaur Grewal, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110845-110845
Closed Access | Times Cited: 2
Kiran T. Thakur, Heena Khan, Amarjot Kaur Grewal, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110845-110845
Closed Access | Times Cited: 2
Quercetin's Neuroprotective Role: Activating Nrf2 Signaling Pathways
Farbod Hatami, Tahereh Farkhondeh, Alia Mohaqeq, et al.
Current Nutrition & Food Science (2024) Vol. 21, Iss. 2, pp. 179-190
Closed Access
Farbod Hatami, Tahereh Farkhondeh, Alia Mohaqeq, et al.
Current Nutrition & Food Science (2024) Vol. 21, Iss. 2, pp. 179-190
Closed Access
The Impact of Sleep and Exercise on Brain Atrophy in Mild Cognitive Impairment
Maamoon Mian, Jihane Tahiri, Saadeddine Habbal, et al.
Mechanisms of Ageing and Development (2024) Vol. 223, pp. 112023-112023
Closed Access
Maamoon Mian, Jihane Tahiri, Saadeddine Habbal, et al.
Mechanisms of Ageing and Development (2024) Vol. 223, pp. 112023-112023
Closed Access
Alzheimer’s disease, epigenetics, and exercise
Stuart M. Raleigh, Tom Cullen
Elsevier eBooks (2021), pp. 201-216
Closed Access | Times Cited: 1
Stuart M. Raleigh, Tom Cullen
Elsevier eBooks (2021), pp. 201-216
Closed Access | Times Cited: 1
